Teva CEO Vigodman steps down as drugmaker seeks direction | The Times of Israel
Teva's CEO on Why the Drugmaker Is Confident Despite Covid-19 | Barron's
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
Activist Investor Jana Partners Takes Stake in Teva, Report Says | Ctech
Teva's CEO Was $2.8 Billion Down on His Second Day on the Job - Bloomberg
Teva Pharmaceuticals Sued by U.S. Over Medicare Kickback Claims - BNN Bloomberg
Teva (TEVA) Agrees to $225 Million Texas Opioid Settlement, AG Says - Bloomberg
Teva: Warren Buffett Messed Things Up For Short-Sellers - Bloomberg
Teva Loses CEO, Leaving Investors to Guess What's Next - Bloomberg
Teva Negotiating Sale of Remaining Women's Health Assets, Report Says | Ctech
Teva Is On The Prowl And Its Investors Are Taking Notice | Mint
Soriot not moving to Teva - Bloomberg - Globes
Allergan becomes largest shareholder in Teva - Globes
Teva: Reportedly Planning Thousands of Layoffs in the U.S. | Fortune
Teva Plunges as U.S. Sales Drop Amid Generic Price Erosion
Teva Pharmaceutical Industries is in talks to manufacture and distribute COVID vaccines | Fortune
Teva's job-cut tally could touch 10K: report | Fierce Pharma
Drug giants line up for Irish legal battle over patents - Independent.ie
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York state - KTVZ
Teva Gets Generic Drugmakers' Backing in Bid to Redo Label Case
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Teva shares jump in Tel Aviv after report of up to 10,000 job cuts | The Times of Israel
Teva bid for Mylan could come today - Bloomberg - Jewish Business News
Teva Pharmaceuticals (TEVA) Stock Gets Upgraded at HSBC - TheStreet
